The Department of Veterans Affairs is seeking a contractor to provide the distribution of BioRad BioPlex laboratory reagents for the Seattle VA Medical Center. The procurement aims to establish a five-year Indefinite Delivery Indefinite Quantity (IDIQ) contract for automated immunoassay instrumentation capable of performing a variety of diagnostic tests, including those for autoimmune diseases and infectious agents. These reagents and instruments are critical for enhancing laboratory capabilities in diagnosing and managing patient care within the VA system. Interested small businesses must submit their quotes by December 19, 2025, at 17:00 Pacific Time, and can direct inquiries to Hector Gonzalez at hector.gonzalez1@va.gov or by phone at 360-553-7632.

36C26026Q0167_1.docx

This document is a combined synopsis/solicitation (RFQ 36C26026Q0167) issued by the Department of Veterans Affairs for a five-year Indefinite Delivery Indefinite Quantity (IDIQ) contract. The purpose is to procure BioRad BioPlex reagents and consumables for laboratory tests at the Seattle VA Medical Center. The contract is 100% set aside for small businesses under NAICS code 325413. The solicitation details the scope of work, including requirements for automated immunoassay instrumentation capable of performing a wide range of tests, system specifications, installation and validation procedures, technical support, maintenance, and staff training. The evaluation will prioritize technical compliance with the Statement of Work over price. Quotes are due by December 19, 2025, 17:00 Pacific Time.

Attachment A Tests List BioRad BioPlex 36C26026Q0167.xlsx

The document lists products and their corresponding product numbers, likely for a government Request for Proposal (RFP) or a grant application. It details various medical testing kits, reagents, calibrator sets, and controls. The products are categorized into several key areas, including ANA Screen, EBV IgG, EBV IgM, ToRC IgG, VASCULITIS (ANCA), APLS IgG, APLS IgM, APLS IgA, CELIAC IgG, CELIAC IgA, MMRV IgG, ANTI-CCP, HSV-1 & HSV-2 IgG, and HIV Ag-Ab. Additionally, it mentions specific components like CMV IgM, Rubella (Qualitative) IgM, Toxoplasma gondii IgM, and Syphilis Total. The latter part of the document indicates an estimated annual amount and pricing structure for these items over five years, including 'Year 1 Price Per Item,' 'Year 1 Total,' 'Year 2 Price Per Item,' and so on, culminating in a 'Total for the 5 Years.' This suggests a procurement request for laboratory supplies and diagnostic kits.

It is the intent of the Pathology Laboratory Medicine of the Seattle VAMC, Department of Veterans Affairs (herein afterwards referred to as Seattle VAMC) to establish a contract for the distribution of BioRad BioPlex laboratory reagents. The Government will award contract to a single Contractor for Automated Immunoassay Instrumentation.  Contractor agrees to the following terms of the contract exclusively with the Seattle VAMC listed by Attachment and awarded in the final contract. The instrument shall be able to perform immunoassays for ANA Screens, Syphilis IgG and RPR, Measles/Mumps/Rubella/Varicella, Herpes Simplex virus (HSV) antibodies, Cytomegalovirus (CMV) antibodies, Epstein-Barr Virus (EBV) antibodies, Vasculitis Panel, Anti-CCP Panel, Celiac Panels, Antiphospholipid Panels, HIV Antibody Panel and Toxoplasma.  Vendor will provide methodology for differentiation the of HIV 1 and HIV 2. Additional tests/reagents/instrumentation may be added to the contract as new technology becomes available on the market and added to the contract.

Total Small Business Set-Aside (FAR 19.5)

Buyer

NAICS

PSC

Set Aside

Original Source